Detection of Non Inhibitory Binding Antibodies to Von Willebrand Factor Affecting the Clearance of VWF:Ag in Von Willebrand Disease

被引：3

作者：

Suiter, Tobias M. ^{[1
]}

Mannucci, Pier Mannuccio ^{[2
,3
]}

Kempton, Christine L. ^{[4
,5
]}

Laffan, Michael ^{[6
]}

Romond, Edward H. ^{[7
]}

Shapiro, Amy D. ^{[8
]}

Birschmann, Ingvild ^{[9
]}

Ragni, Margaret V. ^{[10
,11
]}

Gill, Joan Cox ^{[12
]}

Yee, Thynn Thynn ^{[13
,14
]}

Klamroth, Robert ^{[15
]}

Horling, Frank M. ^{[16
]}

Reipert, Birgit M. ^{[1
]}

Turecek, Peter L. ^{[1
]}

Varadi, Katalin ^{[1
]}

Chapman, Miranda ^{[1
]}

Engl, Werner ^{[1
]}

Wong, Wing Yen ^{[17
]}

Ewenstein, Bruce M. ^{[17
]}

机构：

[1] Baxter Innovat GmbH, Vienna, Austria

[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, Dept Internal Med & Med Specialties, Milan, Italy

[3] Fdn Milano, Sci Direct, Milan, Italy

[4] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA

[5] Emory Univ, Sch Med, Dept Hematol Oncol, Atlanta, GA USA

[6] Imperial Coll Sch Med, Hammersmith Hosp, Dept Hematol, London, England

[7] Univ Kentucky, Hemophilia Treatment Ctr, Lexington, KY USA

[8] Indiana Hemophilia & Thrombosis Ctr, Indianapolis, IN USA

[9] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, D-3000 Hannover, Germany

[10] Univ Pittsburgh, Dept Med, Div Hematol Oncol, Pittsburgh, PA USA

[11] Hemophilia Ctr Western Penn, Pittsburgh, PA USA

[12] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[13] Royal Free Hosp, Haemophilia Ctr, London NW3 2QG, England

[14] Royal Free Hosp, Thrombosis Unit, London NW3 2QG, England

[15] Vivantes Klinikum Friedrichshain, Klini Innere Med Angiol & Haemostaseol, Berlin, Germany

[16] Baxter BioSci, Immunol, Vienna, Austria

[17] Baxter Healthcare Corp, Westlake Village, CA USA

来源：

BLOOD | 2011年 / 118卷 / 21期

关键词：

D O I：

10.1182/blood.V118.21.2275.2275

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：987 / 988

页数：2

共 50 条

[1] Detection of non inhibitory binding antibodies to von Willebrand factor affecting the clearance of VWF:Ag in von Willebrand disease
Suiter, T. M.
Mannucci, P. M.
Kempton, C.
Laffan, M.
Romond, E. H.
Shapiro, A.
Birschmann, I.
Ragni, M. V.
Gill, J. C.
Yee, T. T.
Klamroth, R.
Horling, F. M.
Reipert, B. M.
Turecek, P. L.
Varadi, K.
Chapman, M.
Engl, W.
Wong, W. Y.
Ewenstein, B. M.
HAEMOPHILIA, 2012, 18 : 42 - 43
[2] Detection of non inhibitory binding antibodies to von Willebrand factor affecting the clearance of VWF: AG in von willebrand disease
Suiter, T.
Mannucci, P. M.
Kempton, C. L.
Laffan, M.
Romond, E. H.
Shapiro, A. D.
Birschmann, I
Ragni, M., V
Gill, J. C.
Yee, T. T.
Klamroth, R.
Horling, F. M.
Reipert, B. M.
Turecek, P. L.
Varadi, K.
Chapman, M.
Engl, W.
Wong, W. Y.
Ewenstein, B. M.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 97 - 98
[3] Detection of non-inhibitory binding antibodies to von Willebrand factor affecting the clearance of VWF:Ag in von Willebrand disease
Suiter, T. M.
Mannucci, P. M.
Kempton, C. L.
Laffan, M.
Romond, E. H.
Shapiro, A. D.
Birschmann, I.
Ragni, M. V.
Gill, J. C.
Klamroth, R.
Reipert, B. M.
Turecek, P. L.
Varadi, K.
Chapman, M.
Engl, W.
Ewenstein, B. M.
HAEMOPHILIA, 2012, 18 : 200 - 200
[4] Clearance of von willebrand factor (VWF) in type 2 von willebrand disease (VWD): the implications of VWF propeptide (VWFPP) and VWF:Ag levels
Haberichter, S. L.
Castaman, G.
James, P. D.
Christopherson, P. A.
Roheghiero, F.
Lillicrap, D.
Montgomery, R. R.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 10 - 10
[5] Detection of type 1 von Willebrand Disease with increased von Willebrand Factor clearance
Meiring, M.
Setlaba, P.
Coetzee, M.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1147 - 1147
[6] Von Willebrand factor binding to heparin in von Willebrand disease
Rastegar-Lari, G
Legendre, P
Ajzenberg, N
Meyer, D
Baruch, D
THROMBOSIS AND HAEMOSTASIS, 1999, : 510 - 511
[7] The challenging management of a child with type 3 von Willebrand disease (VWD) and antibodies to von Willebrand factor (VWF)
Platokouki, H.
Pergantou, H.
Xafaki, P.
Adamtziki, E.
HAEMOPHILIA, 2012, 18 : 44 - 44
[8] von Willebrand Factor Propeptide (VWFPP) to von Willebrand factor antigen (VWF:AG) ratio in different subtypes of congenital and acquired von Willebrand disease (VWD)
Stufano, F.
Canciani, M. T.
Baronciani, L.
Cozzi, G.
La Marca, S.
Pagliari, M. T.
Oya, Garcia, I
Siboni, S. M.
Peyvandi, F.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 46 - 47
[9] von Willebrand disease caused by accelerated clearance of VWF
Montgomery, R. R.
Haberichter, S. L.
HAEMOPHILIA, 2010, 16 : 84 - 84
[10] Quantitation of binding of Ricinus communis Agglutinin I to von Willebrand factor (VWF):: Investigation of relationship with plasma clearance of VWF in type 1 von Willebrand disease.
Millar, CM
Riddell, AF
Brown, SA
BLOOD, 2005, 106 (11) : 215A - 216A

← 1 2 3 4 5 →